✦ LIBER ✦

PD-151 Mutations in the epidermal growth factor receptor (EGFR): Retro-and prospective observations in non-small cell lung cancer (NSCLC) patients (pts) treated with gefitinib

✍ Scribed by Nederlof, P.; Boerrigter, L.; van 't Veer, L.; Baas, P.; van Zandwijk, N.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical predictors versus epidermal gro

✍ Han, Sae-Won; Kim, Tae-You; Lee, Kyung-Hun; Hwang, Pil Gyu; Jeon, Yoon Kyung; Oh 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 332 KB

Erlotinib as first-line treatment of Eur

✍ Petruzelka, Lubos 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 43 KB

Predictive and Prognostic Impact of Epid

✍ Han, S.-W. 📂 Article 📅 2005 🏛 American Society of Clinical Oncology 🌐 English ⚖ 132 KB

Epidermal growth factor receptor polymor

✍ Liu, G; Gurubhagavatula, S; Zhou, W; Wang, Z; Yeap, B Y; Asomaning, K; Su, L; He 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 130 KB

Prospective phase II study of gefitinib

✍ Sugio, Kenji; Uramoto, Hidetaka; Onitsuka, Takamitsu; Mizukami, Makiko; Ichiki, 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 181 KB

‘Targeting’ the epidermal growth factor

✍ William Pao; Vincent A. Miller; Mark G. Kris 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 182 KB